Realta Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,966
Closed -$451K 324
2024
Q4
$451K Buy
+7,966
New +$445K 0.18% 115
2024
Q3
Sell
-11,411
Closed -$474K 395
2024
Q2
$474K Sell
11,411
-2,110
-16% -$94.4K 0.09% 232
2024
Q1
$733K Buy
13,521
+2,399
+22% +$122K 0.15% 157
2023
Q4
$571K Sell
11,122
-4,541
-29% -$238K 0.13% 199
2023
Q3
$1M Sell
15,663
-1,067
-6% -$65.4K 0.23% 103
2023
Q2
$1.07M Sell
16,730
-661
-4% -$44.3K 0.23% 100
2023
Q1
$1.21M Sell
17,391
-1,395
-7% -$98.4K 0.29% 86
2022
Q4
$1.35M Sell
18,786
-164
-0.9% -$12.4K 0.33% 71
2022
Q3
$1.35M Sell
18,950
-278
-1% -$20.2K 0.35% 60
2022
Q2
$1.48M Sell
19,228
-103
-0.5% -$7.84K 0.36% 60
2022
Q1
$1.41M Sell
19,331
-656
-3% -$44K 0.28% 79
2021
Q4
$1.25M Buy
19,987
+883
+5% +$51.8K 0.27% 83
2021
Q3
$1.13M Buy
19,104
+266
+1% +$17.5K 0.27% 86
2021
Q2
$1.26M Sell
18,838
-416
-2% -$27.1K 0.3% 84
2021
Q1
$1.22M Buy
19,254
+4,773
+33% +$297K 0.32% 76
2020
Q4
$898K Sell
14,481
-1,512
-9% -$93K 0.25% 90
2020
Q3
$964K Sell
15,993
-7,390
-32% -$445K 0.32% 72
2020
Q2
$1.38M Buy
23,383
+2,004
+9% +$120K 0.45% 46
2020
Q1
$1.19M Sell
21,379
-6,546
-23% -$400K 0.51% 39
2019
Q4
$1.59M Buy
27,925
+5,493
+24% +$315K 0.44% 39
2019
Q3
$1.14M Buy
22,432
+2,865
+15% +$135K 0.31% 59
2019
Q2
$894K Buy
19,567
+12,094
+162% +$563K 0.25% 89
2019
Q1
$356K Buy
+7,473
New +$372K 0.16% 184

Other funds holding BMY

Realta Investment Advisors's BMY Position: Q1 2025 in Review

Realta Investment Advisors sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 7,966 shares — an estimated $451K sold.

Realta Investment Advisors first reported a position in BMY in Q1 2019 and held it in 23 quarters. The position peaked at $1.59M in Q4 2019. 2,476 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

  • Realta Investment Advisors reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
  • Realta Investment Advisors sold 7,966 Bristol-Myers Squibb shares in Q1 2025, an estimated $451K.
  • Realta Investment Advisors first reported a position in Bristol-Myers Squibb in Q1 2019 and held it in 23 quarters.
  • Realta Investment Advisors's Bristol-Myers Squibb position peaked at $1.59M in Q4 2019.
  • 2,476 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Realta Investment Advisors's 13F filing for Q1 2025, filed 1 May 2025.